Spring Bank Pharmaceuticals, Inc.·4

Mar 1, 4:01 PM ET

Driscoll Martin J 4

4 · Spring Bank Pharmaceuticals, Inc. · Filed Mar 1, 2018

Insider Transaction Report

Form 4
Period: 2018-02-28
Driscoll Martin J
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2018-02-28$12.83/sh+1,000$12,83056,400 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION